SARA WEISKIRCH: Open Payments
NPI 1851885933 · WEST HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,674 in 64 payments from 19 companies in 2025. Trend: 2023 $3,036 · 2024 $3,834 · 2025 $2,674
Food & beverage: $2,075Consulting: $500Education: $99
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 4 | $556 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $243 |
| LEO Pharma Inc. | 11 | $240 |
| Galderma Laboratories, L.P. | 5 | $235 |
| Amgen Inc. | 5 | $206 |
| Arcutis Biotherapeutics, Inc. | 3 | $186 |
| GENZYME CORPORATION | 4 | $176 |
| Incyte Corporation | 7 | $149 |
| Organon LLC | 1 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $127 |
Products named: DUPIXENT, NEMLUVIO, ANZUPGO, Zoryve, OPZELURA, VTAMA, ILUMYA, Otezla.
Industry payments across CA — which companies pay providers there.
